Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Levomerc vs Tavanic (Levofloxacin)
NCT05339295Phase 1Completed
- Sponsor
- University of Karachi
- Start
- Jul 2012
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of levofloxacin in bacterial infection (2 arms), sponsored by University of Karachi. Primary endpoints: Maximum Plasma Concentration at 24 hours, Time to Maximum Plasma Concentration at 24 hours and 1 more. Started Jul 2012; status: completed.
02
Drugs
levofloxacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT05339295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05339295.